Antigen processing and presentation of exogenous peptide antigen via MHC class II

pathway activity — cross-omics
GO:0019886Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Antigen processing and presentation of exogenous peptide antigen via MHC class II pathway is significantly associated with the RNA expression of multiple genes, with the LUAD cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are PTPN22, HLA-DMA, and HLA-DPA1, each associated with the pathway in up to 10 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Antigen processing and presentation of exogenous peptide antigen via MHC class II activity versus PTPN22 in LUAD (Pearson r = 0.38).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUADPTPN22 →+0.843+0.228<.001<.001310
HNSCHLA-DMA →+1.055+0.269<.001<.001310
COADHLA-DPA1 →+1.328+0.175<.001<.001310
HNSCC1QC →+1.166+0.191<.001<.001310
BRCAAPOBEC3H →+0.798+0.254<.001<.00139
HNSCTNFAIP8L2 →+0.730+0.223.001<.00139
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0019886 vs PTPN22 — LUAD

Per-sample scatter of Antigen processing and presentation of exogenous peptide antigen via MHC class II activity vs PTPN22 in LUAD.

Explore this scatter interactively →

Exploration